ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in ...
WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...
Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced today the operational readiness of its new aseptic drug product filling line in Stein (CH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results